Haloperidol 4-(4-(4-氯苯基)-4-羟基哌啶-1-基)-1-(4-氟苯基)丁-1-酮

CAS 52-86-8 MFCD00051423

化学结构图

52-86-8
SMILES: O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1

化学属性

Mol. FormulaC21H23ClFNO2
Mol. Weight376
TSCANo
Appearance 白色或类白色结晶性粉末。熔点148-149.4℃。溶于氯仿、甲醇、丙酮、苯、稀酸,在水中的溶解度1.4mg/100ml,微溶于乙醚。无臭、无味。 powder
Solubility45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.39 mg/mL
Melting Point150.0 to 153.0 deg-C
Density1.3

别名和识别编码

Chemical NameHaloperidol
CAS Number52-86-8
Synonym 1- 1-(4-氟苯基)-4-[4-(4-氯苯基)-4-羟基-1-哌啶基]-1-丁酮 1-butanone,4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophen 4-(4-(p-Chlorophenyl)-4-hydroxypiperidi 4-(4-(p-chlorophenyl)-4- 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4’-fluorobutyrophenone 4-(4-(para-Chlorophenyl 4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenone 4-(4-hydroxy-4’-chloro-4-phenylpiperidino)-4’-fluorobutyrophenone 4-[4-(4-CHLOROPHENYL)-4-HYDROXY-1-PIPERIDINYL]-1-(4-FLUOROPHENYL)-1-BUTANONE 4-[4-(4-CHLOROPHENYL)-4-HYDROXYPIPERIDINO 4-[4-(4-Chlorophenyl 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone 4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone 4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone; 4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-4’-(4-flurophenyl)-1-butanone 4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone 4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone 4’-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-butyrophenon 4’-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)bu 4’-fluoro-4-(4-hydroxy-4-(4’-chlorophenyl)piperidino)butyrophenone AKOS 91337 Aldo Aloperidin Bioperidolo Brotopon Einalon S HALOPERIDOL R-1625 卤吡醇 氟哌丁苯 氟哌丁苯,氟哌啶醇 氟哌啶醇 氟哌醇
MDL NumberMFCD00051423
PubChem Substance ID87571270
EC Number200-155-6
Merck Number4598
Reaxys-RN331267
Beilstein Registry Number21(5)2,377
Chemical Name Translation4-(4-(4-氯苯基)-4-羟基哌啶-1-基)-1-(4-氟苯基)丁-1-酮
Wiswesser Line NotationT6NTJ A3VR DF& DQ DR DG
LabNetwork Molecule IDLN00194137
InChIInChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • {SNA} Antagonists, Application Index, Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Biochemicals and Reagents, Cell Biology, Cell Signaling Enzymes, Cell Signaling and Neuroscience, Dopaminargics - Antagonists, Dopaminergics, Enzymes, Inhibitors, and Substrates, GPCR Modulators, GPCR Proteins, Modulators and Antibodies, H, Inhibitors, Johnson & Johnson, Membrane Protein Biology Tools, Neuroscience, Neurotransmission, Neurotransmitters, Proteins and Derivatives, Substrates, Xenobiotics and Drug Metabolism
  • {SNA} Antagonists, Application Index,
  • {SNA} Analytic

产品应用

  • 丁酰苯类抗精神病药(Butyrophenone antipsychotic), D2, D3, 和 D4 多巴胺受体拮抗物。该品为丁酰苯类抗精神病药中最常用的药物,且列入《国家基本药物目录》,过去称为强安定剂,主要用于控制精神分裂证及其他具有幻觉、妄想、兴奋、冲动等症关的疾病,氟哌啶醇主要用于抗急、慢性精神分裂证的躁狂和幻觉,对控制兴奋躁动效果显著,但对精神分裂症的抑郁和淡漠无效,大鼠口服LD50为165mg/kg。

相关文献及参考

  • [2]. Shah NS, et al. Effects of chlorpromazine and haloperidol on the disposition of mescaline-14C in mice. J Pharmacol Exp Ther. 1973 Aug;186(2):297-304
  • Janicki, C.A., et al.: Anal. Profiles Drug Subs., 9, 341 (1980),
  • [1]. Furuta Y, et al. Effects of enzyme inhibitors of catecholamine metabolism and of haloperidol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs. Br J Pharmacol. 1973 Jan;47(1):77-84
  • [1]. Furuta Y, et al. Effects of enzyme inhibitors of catecholamine metabolism and of haloperidol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs. Br J Pharmacol. 1973 Jan;47(1):77-84
  • [2]. Shah NS, et al. Effects of chlorpromazine and haloperidol on the disposition of mescaline-14C in mice. J Pharmacol Exp Ther. 1973 Aug;186(2):297-304

安全信息

GHS Symbol
Precautionary statements
  • P201 Obtain special instructions before use. 使用前获取专门指示。
  • P202 Do not handle until all safety precautions have been read and understood. 已阅读并理解所有的安全预防措施之前,切勿操作。
  • P260 Do not breathe dust/fume/gas/mist/vapours/spray. 不要吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
  • P263 Avoid contact during pregnancy/while nursing. 怀孕/哺乳期间避免接触。
  • P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
  • P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西,喝水或吸烟。
  • P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
  • P301+P310+P330
  • P302+P350
  • P302+P352+P332+P313+P362+P364
  • P305+P351+P338+P337+P313
  • P308+P311
  • P332+P313
  • P337+P313
  • P362 Take off contaminated clothing and wash before reuse. 脱掉污染的衣服,清洗后方可重新使用
  • P405 Store locked up. 上锁保管。
  • P501 Dispose of contents/container to..… 处理内容物/容器.....
Hazard statements
  • H301 Toxic if swallowed 吞食有毒
  • H315 Causes skin irritation 会刺激皮肤
  • H317 May cause an allergic skin reaction 可能导致皮肤过敏
  • H319 Causes serious eye irritation 严重刺激眼睛
  • H335 May cause respiratory irritation 可能导致呼吸道刺激
  • H361 Suspected of damaging fertility or the unborn child 怀疑对生育能力或未出生婴儿造成伤害
WGK Germany3
Signal word Danger
Hazard Codes T
Safety Statements
  • S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后,立即用大量水冲洗并征求医生意见;
  • S53 Avoid exposure - obtain special instructions before use 避免接触,使用前获得特别指示说明;
  • S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时,立即求医(可能时出示标签);
  • S36/37/39 Wear suitable protective clothing, gloves and eye/face protection 穿戴适当的防护服、手套和眼睛/面保护;
  • S24 Avoid contact with skin 避免皮肤接触;
  • S20 When using do not eat or drink 使用时,不得进食,饮水;
  • S37 Wear suitable gloves 戴适当手套;
  • S60 This material and its container must be disposed of as hazardous waste 该物质及其容器必须作为危险废物处置;
Risk Statements
  • R36/37/38 Irritating to eyes, respiratory system and skin 对眼睛、呼吸系统和皮肤有刺激性
  • R61 May cause harm to the unborn child 可能对未出生的婴儿导致伤害
  • R60 May impair fertility 可能降低生殖能力
  • R25 Toxic if swallowed 吞咽有毒
  • R43 May cause sensitisation by skin contact 皮肤接触会产生过敏反应
UN Number 2811 UN 2811 6.1/PG 3 UN2811
RTECSEU1575000
Packing GroupIII
Hazard Class6.1
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 25 mg/kg/5D-C
TOXIC EFFECTS :
   Tumorigenic - Carcinogenic by RTECS criteria
   Liver - tumors
   Blood - leukemia
REFERENCE :
   CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
   Southfield Road, Eynsham, Oxford OX8 1JJ, UK)  V.1-    1980-
   Volume(issue)/page/year: 3,223,1982

TYPE OF TEST            : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 50 mg/kg/10D-C
TOXIC EFFECTS :
   Tumorigenic - Carcinogenic by RTECS criteria
   Gastrointestinal - tumors
   Blood - leukemia
REFERENCE :
   CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
   Southfield Road, Eynsham, Oxford OX8 1JJ, UK)  V.1-    1980-
   Volume(issue)/page/year: 3,223,1982

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 128 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   ARZNAD Arzneimittel-Forschung. Drug Research.  (Editio Cantor Verlag,
   Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.)  V.1-    1951-
   Volume(issue)/page/year: 24,45,1974

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Primate - monkey
DOSE/DURATION           : >1250 ug/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   ARZNAD Arzneimittel-Forschung. Drug Research.  (Editio Cantor Verlag,
   Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.)  V.1-    1951-
   Volume(issue)/page/year: 11,932,1961

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE

{haz

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Unreported
SPECIES OBSERVED        : Human - infant
DOSE/DURATION           : 280 ug/kg
TOXIC EFFECTS :
   Behavioral - excitement
   Behavioral - irritability
   Behavioral - aggression
REFERENCE :
   APAEEL Acta Paediatrica.  (Scandinavian University Press, POB 2959 Toeyen,
   N-0608 Oslo, Norway) V.81-    1992

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Mammal - species unspecified
DOSE/DURATION           : 80 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   DANKAS Doklady Akademii Nauk SSSR.  Proceedings of the Academy of Sciences
   of the USSR.  For English translation, see DBIOAM and DKBSAS.  (V/O
   Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-    1933-
   Volum

TYPE OF TEST            : Cytogenetic analysis
TEST SYSTEM             : Human Fibroblast
DOSE/DURATION           : 10 gm/L
REFERENCE :
   AMBUCH Acta Medica Bulgarica.  (Durzhavno Izdatelstvo Meditsina i
   Fizkultura, Pl. Slaveikov 11, Sofia, Bulgaria)  V.1-    1973-
   Volume(issue)/page/year: 6,42,1979

TYPE OF TEST            : Sex chromosome loss and nondisjunction
ROUTE OF EXPOSURE       : Oral
TEST SYSTEM             : Insect - Drosophila melanogaster
DOSE/DURATION           : 200 mg
REFERENCE :
   SOGEBZ Soviet Genetics.  English translation of GNKAA5.  (Plenum Pub. Corp.,
   233 Spring St., New York, NY 10013)  V.2-    1966- Volume(issue)/page/year:
   7,1042,1971

TYPE OF TEST            : Mutation in microorganisms
TEST SYSTEM             : Bacteria - Salmonella typhimurium
DOSE/DURATION           : 100 nmol/plate
REFERENCE :
   CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
   Southfield Road, Eynsham, Oxford OX8 1JJ, UK)  V.1-    1980-
   Volume(issue)/page/year: 3,223,1982

TYPE OF TEST            : Sister chromatid exchange
ROUTE OF EXPOSURE       : Intraperitoneal
TEST SYSTEM             : Rodent - mouse
DOSE/DURATION           : 285 ug/kg
REFERENCE :
   EMMUEG Environmental and Molecular Mutagenesis.  (Alan R. Liss, Inc., 41 E.
   11th St., New York, NY 10003)  V.10-    1987-  Volume(issue)/page/year:
   10,433,1987

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 10500 ug/kg
SEX/DURATION            : female 8-14 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
   resorbed implants per total number of implants)
REFERENCE :
   ARZNAD Arzneimittel-Forschung. Drug Research.  (Editio Cantor Verlag,
   Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.)  V.1-    1951-
   Volume(issue)/page/year: 18,1420,1968

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 60 mg/kg
SEX/DURATION            : female 1-12 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Maternal Effe

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 70 mg/kg
SEX/DURATION            : female 6-12 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - eye/ear
REFERENCE :
   ARZNAD Arzneimittel-Forschung. Drug Research.  (Editio Cantor Verlag,
   Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.)  V.1-    1951-
   Volume(issue)/page/year: 18,1420,1968

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 21 mg/kg
SEX/DURATION            : female 6-12 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured
   before birth)
REFERENCE :
   ARZNAD Arzneimittel-Forschung. Drug Research.  (Editio Cantor Verlag,
   Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.)  V.1-    1951-
   Volume(issue)/page/year: 18,1

TYPE OF TES

其他信息

  • 氟哌啶醇价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2014/06/02 H0912 氟哌啶醇 Haloperidol 5G 874元 2014/06/02 H0912 氟哌啶醇 Haloperidol 25G 2470元
  • TCI Shanghai:氟哌啶醇 Haloperidol,>;98.0%(LC)(T)(52-86-8)
  • 方法一:由4-对氯苯-4-羟基哌(见09670)与γ-氯代对氟苯丁酮缩合而得。中间体γ-氯代氟苯丁酮是由氟苯、γ-丁内酯、氯化亚砜为原料制得(见09060)。
  • Sigma Aldrich:52-86-8(sigmaaldrich)
  • 用途一:该品为丁酰苯类抗精神病药中最常用的药物,且列入《国家基本药物目录》。抗精神病药物,过去称为强安定剂,主要用于控制精神分裂证及其他具有幻觉、妄想、兴奋、冲动等症关的疾病。氟哌啶醇主要用于抗急、慢性精神分裂证的躁狂和幻觉,对控制兴奋躁动效果显著,但对精神分裂症的抑郁和淡漠无效。大鼠口服LD50为165mg/kg。
  • 溶于氯仿、甲醇、乙醇、丙酮、苯、稀酸和DMSO,在水中的溶解度1.4mg/100ml,微溶于乙醚,无臭、无味,无臭,无味,几乎不溶于水,其盐酸盐易溶于水。
  • 图谱信息:氟哌啶醇(52-86-8)红外图谱(IR1) 氟哌啶醇(52-86-8)核磁图( 13 CNMR) 氟哌啶醇(52-86-8)质谱(MS) 氟哌啶醇(52-86-8)红外图谱(IR2) 氟哌啶醇(52-86-8)核磁图( 1 HNMR)
  • 氟哌啶醇价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2011/04/16 H0912 氟哌啶醇 Haloperidol 5G 721元 2011/04/16 H0912 氟哌啶醇 Haloperidol 25G 2030元
  • MOL 文件:52-86-8.mol
  • 抗精神病药:氟哌啶醇属于丁酰苯类抗精神病药,又名氟哌丁苯、氟哌醇、卤吡醇,主要用于治疗各种急、慢性精神分裂症,躁狂症,反应性精神病及其他具有兴奋、躁动幻觉、妄想等症状的重症精神病,特别是急性青光眼和伴有攻击行为的偏执型精神分裂症,因本品心血管系不良反应较少,也可用于脑器质性精神障碍、焦虑性神经症和老年性精神障碍。 其药理作用与酚噻嗪类抗精神分裂药类似,通过阻断脑内多巴胺受体,抑制多巴胺神经原的效应,从而增快和增多脑内多巴胺的转化。有很好的抗幻觉妄想和抗兴奋躁动作用,阻断锥体外系多巴胺的作用较强,镇吐作用亦较强,但镇静、阻断肾上腺素受体及胆碱受体作用较弱,这就需要与其它药物进行配合服用。此外,还可阻断植物神经系统的α肾上腺素受体。产生相应的生理影响。 氟哌啶醇口服后有70%被吸收,血浆蛋白结合率高。3~6小时血药浓度达峰值。半衰期约为21小时,在肝内代谢,随尿排泄。 其他常见丁酰苯类抗精神病药:苯哌利多、三氟哌啶醇、氟司必林、五氟利多。
  • color:white
  • MSDS 信息:4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone(52-86-8).msds
  • 用途二:丁酰苯类抗精神病药(Butyrophenone antipsychotic), D2, D3, 和 D4 多巴胺受体拮抗物。该品为丁酰苯类抗精神病药中最常用的药物,且列入《国家基本药物目录》,过去称为强安定剂,主要用于控制精神分裂证及其他具有幻觉、妄想、兴奋、冲动等症关的疾病,氟哌啶醇主要用于抗急、慢性精神分裂证的躁狂和幻觉,对控制兴奋躁动效果显著,但对精神分裂症的抑郁和淡漠无效,大鼠口服LD50为165mg/kg。
  • 上游原料:氧氯化硫 --> gamma-丁内酯 --> 氟化苯 --> 苯丁酮

系列性分类


相关产品推荐